Sinovac Biotech, Ltd. SVA
6.47 USD 0.00 (+0.00%)
At closeOct 28, 2026, 4:00 PM EDT
6.47 Day range 6.47
6.47 52-week range 6.47
- YTD
- 0.00%
- 1 year
- 0.00%
News
defenseworld.net Sernova, Seraxis Aim for Type 1 Diabetes ‘Functional Cure’ With BetaNova Merger Sernova (TSE: SVA) and Seraxis plan to combine to form BetaNova Biotherapeutics, a company focused on developing cell-based therapies intended to reduce or eliminate the need for external insulin in…
businesswire.com SINOVAC Reports Unaudited First Half of 2026 Financial Results BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited financial…
businesswire.com SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline…
businesswire.com SINOVAC Regained Compliance With the Nasdaq Global Market's Listing Requirements BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification…
businesswire.com SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on…
businesswire.com SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification…
businesswire.com SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline…
businesswire.com SINOVAC Reports Unaudited First Half of 2025 Financial Results BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results…
businesswire.com SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report…
businesswire.com SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel…
businesswire.com SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High…
businesswire.com Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a…
businesswire.com Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has…
businesswire.com SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it…
prnewswire.com Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment BOSTON , Nov. 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac…
businesswire.com SINOVAC Announces Appointment of Independent Auditor BEIJING--(BUSINESS WIRE)--The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today…
businesswire.com SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”) today issued the following update to set the record straight regarding the Special…
businesswire.com Newly Elected Directors of Sinovac Hold the First Board Meeting BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the…
businesswire.com SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent…
businesswire.com SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 
benzinga.com Earnings Scheduled For November 28, 2016 
benzinga.com Earnings Scheduled For August 23, 2016 - benzinga.com Earnings Scheduled For May 28, 2013
benzinga.com Earnings Scheduled For March 29